AOB

[la-onda]

2)AOB: Short Interest UP 4.0% to 12.2M in Aug 2007
Wednesday, August 22, 2007 10:45ET

According to new short interest data from NYSE, short interest for American Oriental Bioengineering Inc (NYSE: AOB) INCREASED 4.0% to 12,175,990 shares for the month ended mid-August, 2007.

SYMBOL      JULY          AUGUST          CHANGE       %CHANGE     DAYS/COVER
--------   -------------   -------------   -------------  ------------  ----------
AOB           11,710,467      12,175,990        +465,523        +3.98%           6

Based on AOB's 20-day average daily share volume of 2,033,885, it would require approximately 6 day(s) of buying to cover this short interest.

&

AOB: Westminster Keeps @ Strong Buy; Keeps Tgt @ $13.8; Analyst Notes
Tuesday , August 21, 2007 16:13ET

Issuer: American Oriental Bioengineering Inc (NYSE: AOB)
Analyst Firm:  Westminster Securities
Ratings Action: REITERATION
Current Rating: Strong Buy
Target Price Action: MAINTAIN
Target Price: $13.80
Analyst Comments: The firm's Strong Buy rating is based on their expectation the company's share price will experience significant appreciation as revenue and net income growth from existing and newly-acquired operations become more visible.

[la-onda]

August 23 Analyst Julie Chen of Brean Murray reiterates his "buy" rating on American Oriental Bioengineering (ticker: AOB). The target price is set to $16.

In a research note published this morning, the analyst mentions that acquisitions are integral to the company's key growth strategy. The sophistication and competence of American Oriental Bioengineering's management, as demonstrated in China, are the primary drivers of the company's success, the analyst says. There are no risks involved in the closing of the Changchun Xinan Pharmaceutical acquisition, Brean Murray believes.

inverted head & shoulder chart pattern